Navigation Links
Dual Therapy Best for Preventing Bleeding After Heart Procedures
Date:6/1/2010

But combined techniques less likely to be used for those at highest risk, study finds

TUESDAY, June 1 (HealthDay News) -- The risk of bleeding in patients undergoing procedures such as balloon angioplasty and stent implants to open blocked arteries can be lowered best through the combined use of vessel-closing devices and a blood thinner, researchers say.

Bleeding is a common complication and can lead to death, but the patients at greatest risk of bleeding are also the least likely to be treated with the lifesaving strategies, the study authors found.

Stent implants and balloon angioplasty -- known as percutaneous coronary interventions -- are performed an estimated one million times each year in the United States.

In the study, researchers from Saint Luke's Mid America Heart Institute in Kansas City, Mo., examined how often patients bled after the artery-opening procedures and how those rates were affected by the closing devices and the blood thinner.

After Dr. Steven P. Marso of Saint Luke's and colleagues analyzed the medical records of over 1.5 million patients who underwent procedures between 2004 and 2008, they found that combined use of the vessel-closing devices and the blood thinner Angiomax (bivalirudin) was most effective at lowering the risk.

Bleeding occurred in 2 percent of cases. However, the combined strategies to prevent it were used more often in low-risk patients (21 percent) than high-risk patients (14 percent).

"The results of this study suggest the need for additional research to better understand why higher-risk patients are least likely to receive bleeding avoidance strategies," the study authors wrote.

The study findings are published in the June 2 issue of the Journal of the American Medical Association.

More information

The U.S. National Heart, Lung and Blood Institute has more on stents and heart care.



-- Randy Dotinga



SOURCE: American Medical Association, news release, June 1, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Blocking DNA repair protein could lead to targeted, safer cancer therapy
2. Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers
3. AthletiCo Physical Therapy Enhances Work Rehabilitation Program by Offering Ergonomics and Job Analysis
4. Research finds surgery outperforms drug therapy in treatment of benign prostatic hyperplasia
5. Response to preoperative therapy may predict survival in pancreatic cancer patients
6. Making Your Way Through the Fog of Chemotherapy
7. Keep Feet Healthy this Summer with Tips from AthletiCo Physical Therapy
8. Antiviral therapy during compensated cirrhosis most cost-effective approach
9. Proton Therapy Carries Precise, Potent Punch Against Cancers for Patients at The Children's Hospital of Philadelphia
10. NYC Chiropractor Expands Practice with Therapy for Muscle and Overuse Injuries
11. AthletiCo's Champaign-Urbana Physical Therapy Center Relocates to 2040 S. Neil in Champaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... (NYLF): Medicine will have the unique opportunity to get hands-on experience in ... high school students an immersive experience to gain invaluable, real-life medical skills that ...
(Date:12/7/2016)... ... 07, 2016 , ... "Today, MHA and mental health advocates ... systems reform legislation in more than fifty years. We applaud the bipartisan action ... elected officials to improving mental health services and supports in our nation. , ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... in their bodies, a researcher at the Icahn School of Medicine at Mount ... The study found that when young children are exposed to secondhand marijuana smoke, ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016   IQuity, Inc., ... that Don Hardison has been ... an executive with extensive experience as CEO, ... and Fortune 500 companies within the molecular, clinical ... extensive marketing and sales experience within the pharmaceutical ...
(Date:12/7/2016)... "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by PNS ... in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially available ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... on Lantus expired in 2014. Lantus is the brand name for ...
(Date:12/7/2016)... Dec. 7, 2016 KEY FINDINGS ... benefits such as reducing loss of blood during ... cardiac arrests, rapid recovery after surgeries, and decreasing ... be segmented into convective warming system, surface warming ... turn reduce the stay at hospitals thus, lowering ...
Breaking Medicine Technology: